arrow
A

Andrea Vingiani

university of milan
H指数:30
被引数:5,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease

浸润性小叶组织学特征的晚期乳腺癌中枢神经系统和软脑膜受累模式:一项针对雌激素受体阳性/HER2阴性疾病的的多中心大型研究

2026-10-210
OA
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy

HER2-low乳腺癌是免疫冷型肿瘤:肿瘤浸润免疫细胞的见解及其对免疫治疗的启示

2025-12-030
OAAI
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer

基因组不稳定性及CCNE1扩增作为分层高级别浆液性卵巢癌的新兴生物标志物

2025-08-070
OA
Advancing breast cancer therapy in the era of molecular diagnostics

分子诊断时代下乳腺癌疗法的进展

2025-05-080
OAAI
Modulation of systemic and intratumor metabolism predicts response to fasting-mimicking diet plus chemotherapy in patients with early TNBC

系统性及肿瘤内代谢的调控预测了空腹模拟饮食联合化疗对早期TNBC患者的反应

2024-09-010
PRE
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer

雌激素受体低和阴性早期乳腺癌的免疫和基因表达谱

2024-07-312
OAAI
Precocious modulation of metabolic and immunological parameters predicts tumor response to fastingmimicking diet plus chemotherapy in patients with early stage TNBC
2024-05-021
PRE
Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches
2024-05-020
PRE
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells

长期多模态记录揭示了休眠乳腺癌细胞的表观遗传适应途径

2024-03-267
OAAI
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
2024-03-011
OAAI
A gene expression-based classifier for HER2-low breast cancer
2024-02-010
OAAI
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
2024-01-301
OAAI
Real-world use of multigene signatures in early breast cancer: differences to clinical trials

多基因签名在早期乳腺癌中的实际应用: 与临床试验的差异

2024-01-241
OAAI